Hypoalgesia elicited by a conditioned stimulus is blocked by a mu, but not a delta or a kappa, opioid antagonist injected into the rostral ventromedial medulla.
The present study investigated the role of micro, delta, and kappa receptors within the RVM in mediating expression of conditional hypoalgesia (CHA). Five groups of rats with RVM cannulae were given daily sessions of paired or unpaired presentations of an auditory CS (white noise) and foot shock across three consecutive days. On the test day, rats in the Paired condition were injected with the micro antagonist CTAP, the delta antagonist naltrindole, the kappa antagonist nor-BNI, or saline. Rats in the Unpaired condition were injected with saline. TFLs were measured before and after injections, as well as during and after presentations of the CS. The results showed that none of the drugs affected baseline TFLs. During CS presentation, rats in the Paired condition injected with saline showed longer TFLs than those in the Unpaired condition given saline, confirming the presence of CHA. Expression of this response was blocked by CTAP, but was unaffected by naltrindole or nor-BNI. These results suggest that mu, but not delta or kappa, opioid receptors in the RVM mediate expression of CHA.
Foo
H
H
School of Psychological Science, La Trobe University, Albury/Wodonga campus, Parkers Road, P.O. Box 821, Wodonga, VIC 3689, Australia Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
Helmstetter
Fred J
FJ
D000818:Animals; D003213:Conditioning, Psychological / Q000187:drug effects; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects*; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010147:Pain Measurement / Q000187:drug effects*; D010446:Peptide Fragments; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors; D017473:Receptors, Opioid, kappa / Q000037:antagonists & inhibitors; D017450:Receptors, Opioid, mu / Q000037:antagonists & inhibitors*; D013004:Somatostatin
C529311:CTAP octapeptide; D009292:Narcotic Antagonists; D010446:Peptide Fragments; D010455:Peptides; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; C051844:norbinaltorphimine; D013004:Somatostatin; D009271:Naltrexone; C055382:naltrindole